Great Lakes NeuroTechnologies Inc., Cleveland, OH, USA.
Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, OH, USA.
J Parkinsons Dis. 2017;7(4):741-747. doi: 10.3233/JPD-171159.
Clinical rating of bradykinesia in Parkinson disease (PD) is challenging as it must combine several movement features into a single score. Additionally, in-clinic assessment cannot capture fluctuations throughout the day.
To evaluate the reliability and responsiveness of a motion sensor-based tablet app for objective bradykinesia assessment in clinic and at home as compared to clinical ratings.
Thirty-two PD patients treated with subthalamic deep brain stimulation (DBS) were outfitted with a motion sensor on the index finger of the more affected hand to perform two repetitions of finger-tapping, hand opening-closing, and arm pronation-supination tasks with DBS on and 10, 20, and 30 minutes after turning DBS off. Tasks were videotaped for blinded clinician rating using the Modified Bradykinesia Rating Scale (MBRS). Participants were then sent home with an app-based system to perform two repetitions of the same tasks six times per day spaced two hours apart, three days per week, for two weeks. Intraclass correlation (ICC) and minimal detectable change (MDC) were calculated.
As the effects of DBS wore off, motion sensors detected worsening of amplitude sooner than did clinician-rated MBRS for all three tasks. ICCs were significantly higher and MDCs were significantly lower for motion sensors in the clinic and at home than for clinician ratings (p < 0.01).
The tablet-based app demonstrated higher reliability and responsiveness in capturing bradykinesia-related tasks in the clinic and at home than did clinician ratings. This tool may enhance the assessment of novel therapies.
临床评估帕金森病(PD)的运动迟缓具有挑战性,因为它必须将多个运动特征综合为一个单一的评分。此外,临床评估无法捕捉全天的波动。
评估基于运动传感器的平板电脑应用程序在诊所和家中进行客观运动迟缓评估的可靠性和反应性,与临床评分相比。
32 名接受丘脑底核深部脑刺激(DBS)治疗的 PD 患者在受影响较大的手的食指上佩戴运动传感器,以执行两次手指敲击、手开合和手臂旋前-旋后任务,DBS 开启和关闭后 10、20 和 30 分钟。任务由临床医生进行盲法评估,使用改良运动迟缓评分量表(MBRS)进行评估。然后,参与者被送回家使用基于应用程序的系统,每天间隔两小时执行相同任务的两次重复,每周三天,持续两周。计算了组内相关系数(ICC)和最小可检测变化(MDC)。
随着 DBS 效果的消退,运动传感器检测到的振幅恶化早于临床医生评估的 MBRS 对所有三个任务。与临床医生评分相比,运动传感器在诊所和家中的 ICC 显著更高,MDC 显著更低(p<0.01)。
基于平板电脑的应用程序在诊所和家中捕捉与运动迟缓相关的任务时,表现出更高的可靠性和反应性,优于临床医生评分。该工具可能增强对新型疗法的评估。